Biotech & Medtech news — Friday 23 October 2026

MedCity News 20:33 UTC

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as priorities for women’s cardiovascular health. The post Where Are the Biggest Opportunities in Women’s…

STAT News 19:19 UTC

You’re reading our ESMO in 30 Seconds newsletter. Sign up here to get updates from the major European cancer conference in your inbox. Hello from Madrid, where this year’s European Society for Medical Oncology conference got off to an…

STAT News 19:16 UTC

Since five members of the American Diabetes Association were ejected from its scientific session in New Orleans on June 5, the professional organization has released two explanations, one apology, one summary of its review of the events…

STAT News 18:55 UTC

Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial, adding to safety concerns about a growing field of research. In a Phase 1 trial that tested the…

STAT News 18:48 UTC

Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit and those that do were generated by a small number of drugmakers, mostly based in Asia, according to a new analysis…

MedCity News 17:46 UTC

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 receptor to treat inflammatory bowel disease. It could compete against Johnson & Johnson’s Icotyde, an oral peptide…

STAT News 16:47 UTC

A multiple sclerosis treatment from Novartis cut by a third the rates of relapses that people with the condition have compared to a standard treatment, data presented Friday show. While that efficacy doesn’t match the performance of a…

STAT News 16:39 UTC

Since the news about Christina Applegate’s multiple sclerosis misdiagnosis was released, texts from friends in disbelief have been popping up on my phone. “How could this happen?” they asked. “I wonder what else it could be?” they…

STAT News 15:59 UTC

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them . Don’t be shy…

STAT News 15:48 UTC

Our colleague Helen Branswell was a renowned infectious disease reporter who earned the respect and admiration of experts and public health officials with her authoritative, prescient reporting on the flu, polio, Ebola and the Covid-19…

BioPharma Dive 15:33 UTC

The latest installment in BioPharma Dive’s data visualization series features a look at the emerging popularity of RNAi developers, and the funding that came with it.

STAT News 15:24 UTC

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla. Joy Jiao, head of life sciences…

STAT News 14:47 UTC

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . As I pondered potential Halloween costumes, I was particularly tickled by an Instagram influencer dressed up as Elizabeth…

STAT News 14:03 UTC

WASHINGTON — The Trump administration late on Thursday proposed a rule that would severely restrict future U.S. investment in the Chinese biotech sector but still allow American drugmakers to buy the rights to medicines invented in the…

MedCity News 13:54 UTC

Ultimately, while clinical training teaches nurses how to care for patients within a system, business education empowers them to design, protect, and scale the system. The post Why an Independent NP Practice Requires an Undergraduate…

STAT News 13:45 UTC

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to manicure the Pharmalot…

STAT News 13:00 UTC

Pathos, an artificial intelligence-driven drug development company, announced on Friday it is raising $237 million in a Series E fundraising round led by Bristol Myers Squibb. The deal brings Pathos’ valuation to approximately $3 billion…

BioPharma Dive 11:00 UTC

Following exits for its subsidiaries Electra Therapeutics and Vega Therapeutics, Star is now mining for a new drug prospect.

STAT News 10:30 UTC

MADRID — The combination of an experimental drug from Tango Therapeutics and Revolution Medicines’ Rasonque led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, clinical trial results reported Friday…

STAT News 08:30 UTC

Everywhere you look this week, it seems everyone has a hot take on the new Elizabeth Holmes documentary, “You Can See Everything.” We’ve even published a couple here on this very site. Earlier this week, a STAT colleague asked in our…

STAT News 08:30 UTC

The approval of daraxonrasib , a new life-extending drug for pancreatic cancer, is the biggest advance in decades against a notoriously hard-to-treat disease. But data readouts don’t show what those extra months mean to patients and their…

STAT News 08:30 UTC

For years, one of my patients lived with chronic pelvic pain that felt like a hot poker in her vagina. After I performed a targeted nerve block with numbing medication, her pain disappeared. Through tears, she told me something I have…

STAT News 08:30 UTC

NATIONAL HARBOR, Md. — Hundreds of people responsible for 73 million Americans’ health care quieted as conference room lights dimmed and Mehmet Oz’s face appeared on giant screens Thursday morning. The Centers for Medicare and Medicaid…

STAT News 08:30 UTC

It’s one of the biggest public health reversals in decades: Opioid overdose deaths are falling faster than at any point in the modern history of the epidemic. After persistently rising for more than 30 years, deaths peaked at 81,806 in…

STAT News 08:30 UTC

When Janet Freeman-Daily, a former aerospace engineer and self proclaimed “science geek,” was diagnosed with lung cancer, she made it her mission to learn about her disease. Her curious nature eventually led her down the path of…

STAT News 07:45 UTC

An experimental Huntington’s drug from Alnylam Pharmaceuticals showed promise in a small study, the company said Friday, suggesting it can partially silence the mutant gene that drives the devastating neurological disorder. Patients who…

arXiv cs.NE (Neural／Bio) 04:00 UTC

arXiv:2610.31339v1 Announce Type: new Abstract: Probabilistic computing has proved useful for combinatorial optimization, but conventional implementations rely on binary stochastic units and sigmoid-based updates. Extending these systems…

arXiv cs.NE (Neural／Bio) 04:00 UTC

arXiv:2610.16102v2 Announce Type: replace Abstract: We argue that tacit knowing is better modelled as an operating regime of a memory than as a kind of content. Our substrate is VaCoAl, an algebro-deterministic XOR-and-shift…

arXiv cs.NE (Neural／Bio) 04:00 UTC

arXiv:2608.00700v2 Announce Type: replace-cross Abstract: The rapid development of Large Language Models (LLMs) has opened new avenues for Automated Heuristic Design (AHD) for solving NP-hard combinatorial optimization problems (COPs)…

arXiv cs.NE (Neural／Bio) 04:00 UTC

arXiv:2610.31326v1 Announce Type: new Abstract: Evolutionary program search with large language models keeps the structure of an evolutionary algorithm and uses the model as its variation operator. Typically, the model generates each…

arXiv cs.NE (Neural／Bio) 04:00 UTC

arXiv:2303.03538v2 Announce Type: replace-cross Abstract: Compact appliance classifiers can support local electricity-load monitoring where memory and computation are constrained. We evaluate adaptive sparse evolutionary training and…

BioPharma Dive 01:37 UTC

Funds from the upsized offering will support a trio of protein-degrading medicines in development for allergic conditions as well as the autoimmune disorder Graves’ disease.